Sanofi Pasteur Reported To Set Phase II India Trials For Dengue Vaccine
This article was originally published in PharmAsia News
Executive Summary
Sanofi Pasteur reportedly is set to begin Phase II trials for its dengue fever vaccine in India, first on adults, then on children with the aim of having it on the market as soon as 2015.